NEW YORK (GenomeWeb) – Laboratory Corporation of America today reported that its third quarter revenues increased 6 percent year over year, driven by a nearly 7 percent gain in test volume and fold-in acquisitions.

The Burlington, NC-based clinical lab and diagnostics developer reported total revenues of $1.55 billion for the three months ended Sept. 30, up from $1.46 billion in Q3 2013 and above the consensus Wall Street estimate of $1.50 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.